Finance

Beta
Lists
COAG:NASDAQ
Hemab Therapeutics Holdings Inc
$38.00
+2.16%
(+0.81) 1D
Jul 10, 3:09:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COAG...
Open
$37.21
High
$38.36
Low
$34.98
Mkt. cap
1.78B
Avg. vol.
286.67K
Volume
140.33K
52-wk high
$38.86
52-wk low
$23.00
No. of employees
72
Open
$37.21
High
$38.36
Low
$34.98
Mkt. cap
1.78B
Avg. vol.
286.67K
Volume
140.33K
52-wk high
$38.86
52-wk low
$23.00
No. of employees
72
News stories
From sources across the web
About Hemab Therapeutics Holdings Inc
CEO-
Employees72
Founded2020
Headquarters-
SectorBiotechnology
Websitehemab.com
Analyst ratings
Based on 5 analysts giving stock ratings to COAG in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for COAG in the last 3 months.
Highest
Current $38.00
$50.00 (+31.56%)
Average
$41.40 (+8.93%)
Lowest
$36.00 (-5.28%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Nierengarten
Wedbush
Buy
Maintained
$42.00
+10.5%
06/29/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$40.00
+5.2%
06/26/2026
Maury Raycroft
Jefferies
Buy
Maintained
$39.00
+2.6%
06/08/2026
Cory Kasimov
Evercore ISI
Buy
Initiated
$50.00
+31.6%
05/26/2026
Richard Law CFA
Goldman Sachs
Buy
Initiated
$36.00
-5.3%
05/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
14.10M
19.46M
Total research and development expenses
-
-
Selling, general, and admin expenses
2.46M
4.15M
Operating expense
16.56M
23.61M
Total operating expenses
16.56M
23.61M
Operating income
-16.56M
-23.61M
Other non operating income
591.00K
-282.00K
EBT including unusual items
-15.50M
-22.68M
EBT excluding unusual items
-15.50M
-22.68M
Income tax expense
-190.00K
12.00K
Effective tax rate
1.23%
-0.05%
Other operating expenses
-
-
Net income
-15.31M
-22.69M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
473.00K
1.22M
Interest expense
-
-
Net interest expenses
473.00K
1.22M
Depreciation and amortization charges
-
-
EBITDA
-16.48M
-23.54M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer